Skip to main content
TipRanks
Go Ultimate75% OFF

Telix Pharmaceuticals Limited Unsponsored ADR (TLX) Financial Statements

14 Followers

Telix Pharmaceuticals Limited Unsponsored ADR Financial Overview

Telix Pharmaceuticals Limited Unsponsored ADR's market cap is currently AU$3.22B. The company's EPS TTM is AU$0.10; its P/E ratio is 97.04; Telix Pharmaceuticals Limited Unsponsored ADR is estimated to report earnings on February 19, 2027, and the estimated EPS forecast is AU$0.06. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueAU$ 789.77MAU$ 783.21MAU$ 502.55MAU$ 160.10MAU$ 7.60M
Gross ProfitAU$ 419.47MAU$ 509.68MAU$ 314.39MAU$ 94.93MAU$ 5.05M
Operating IncomeAU$ 17.46MAU$ 82.13MAU$ 15.84MAU$ -91.93MAU$ -81.25M
EBITDAAU$ 52.30MAU$ 100.57MAU$ 22.97MAU$ -92.84MAU$ -70.07M
Net Income―AU$ 49.92MAU$ 5.21MAU$ -104.08MAU$ -80.51M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 141.82MAU$ 710.35MAU$ 123.24MAU$ 116.33MAU$ 22.04M
Total AssetsAU$ 1.18BAU$ 1.52BAU$ 398.30MAU$ 255.35MAU$ 109.81M
Total DebtAU$ 466.96MAU$ 581.45MAU$ 17.45MAU$ 10.45MAU$ 2.54M
Net DebtAU$ 325.14MAU$ -128.90MAU$ -105.79MAU$ -105.88MAU$ -19.50M
Total LiabilitiesAU$ 766.49MAU$ 948.22MAU$ 249.39MAU$ 175.35MAU$ 106.17M
Stockholders' EquityAU$ 415.24MAU$ 568.21MAU$ 148.91MAU$ 80.01MAU$ 2.16M
Cash Flow
Free Cash FlowAU$ -54.25MAU$ 28.71MAU$ 14.21MAU$ -71.01MAU$ -60.67M
Operating Cash FlowAU$ -16.99MAU$ 43.03MAU$ 23.88MAU$ -63.97MAU$ -59.33M
Investing Cash FlowAU$ -280.93MAU$ -135.17MAU$ -25.49MAU$ -17.00MAU$ -2.73M
Financing Cash FlowAU$ -3.65MAU$ 638.92MAU$ 10.19MAU$ 174.96MAU$ 2.85M

Currency in AUD

Telix Pharmaceuticals Limited Unsponsored ADR Earnings and Revenue History

-500M0500M1B-8000 %-4000 %0 %4000 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

Telix Pharmaceuticals Limited Unsponsored ADR Liabilities to Assets

0600M1.2B1.8B0 %40 %80 %120 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Telix Pharmaceuticals Limited Unsponsored ADR Cash Flow

-500M-250M0250M500M750M201720182019202020212022202320242025OperatingInvestingFinancing

Telix Pharmaceuticals Limited Unsponsored ADR Forecast EPS vs Actual EPS

000.10.10.20.20.3Q2 24Q4 24Q2 25Q4 25Q2 26Q4 26EPS EstimateBeatMiss